All Stories

  1. New organisation for follow-up and assessment of treatment efficacy in sleep apnoea
  2. Obstructive sleep apnoea in acute coronary syndrome
  3. Unique sleep‐stage transitions determined by obstructive sleep apnea severity, age and gender
  4. Decrease in blood pressure during continuous positive airway pressure treatment for obstructive sleep apnoea: still searching for predictive factors
  5. Cancer prevalence is increased in females with sleep apnoea: data from the ESADA study
  6. Obstructive sleep apnea and comorbidities: a dangerous liaison
  7. Blood-pressure variability in patients with obstructive sleep apnea: current perspectives
  8. Beneficial Effects of CPAP Treatment in High-risk Subgroups of OSA Patients: Some Evidence, at Last
  9. Association of bronchial asthma with obstructive sleep apnea
  10. Change in weight and central obesity by positive airway pressure treatment in obstructive sleep apnea patients: longitudinal data from the ESADA cohort
  11. Sleep apnea and its role in transportation safety
  12. Abnormal thyroid hormones and non-thyroidal illness syndrome in obstructive sleep apnea, and effects of CPAP treatment
  13. Introducing a core curriculum for respiratory sleep practitioners
  14. Advances in asthma pathophysiology: stepping forward from the Maurizio Vignola experience: FIGURE 1
  15. Diabetes Mellitus Prevalence and Control in Sleep-Disordered Breathing
  16. Driving habits and risk factors for traffic accidents among sleep apnea patients - a European multi-centre cohort study
  17. Sleep apnoea severity independently predicts glycaemic health in nondiabetic subjects: the ESADA study
  18. Brain and Breathing
  19. Hyperuricemia and non-dipping blood pressure
  20. Gender-specific anthropometric markers of adiposity, metabolic syndrome and visceral adiposity index (VAI) in patients with obstructive sleep apnea
  21. Sleep apnoea and metabolic dysfunction
  22. Plasma leptin and vascular endothelial growth factor (VEGF) in normal subjects at high altitude (5050 m)
  23. Recommendations for the management of patients with obstructive sleep apnoea and hypertension
  24. Obesity and intermittent hypoxia increase tumor growth in a mouse model of sleep apnea
  25. Effects of exercise training on airway closure in asthmatics
  26. Position paper on the management of patients with obstructive sleep apnea and hypertension
  27. Pre-treatment with mesenchymal stem cells reduces ventilator-induced lung injury
  28. Early and mid-term effects of obstructive apneas in myocardial injury and inflammation
  29. Metabolic syndrome, insulin resistance and sleepiness in real-life obstructive sleep apnoea
  30. Reduced apoptosis of CD8+ T-Lymphocytes in the airways of smokers with mild/moderate COPD
  31. Adipose tissue in obesity and obstructive sleep apnoea
  32. Sleep HERMES: a European Core Syllabus in respiratory disorders during sleep
  33. Sleep HERMES: a European training project for respiratory sleep medicine
  34. Tissue Oxygenation in Brain, Muscle, and Fat in a Rat Model of Sleep Apnea: Differential Effect of Obstructive Apneas and Intermittent Hypoxia
  35. The European Sleep Apnoea Database (ESADA): report from 22 European sleep laboratories
  36. Obstructive sleep apnoea and metabolic impairment in severe obesity
  37. Blood Pressure Changes After Automatic and Fixed CPAP in Obstructive Sleep Apnea: Relationship with Nocturnal Sympathetic Activity
  38. Obstructive sleep apnoea and metabolic syndrome in Mediterranean countries
  39. Management of obstructive sleep apnea in Europe
  40. Hemopoietic and angiogenetic progenitors in healthy athletes: different responses to endurance and maximal exercise
  41. Bronchial epithelial damage after a half-marathon in nonasthmatic amateur runners
  42. Environmental conditions, air pollutants, and airway cells in runners: A longitudinal field study
  43. Sleep, sleep-disordered breathing and metabolic consequences
  44. Metabolic aspects of obstructive sleep apnoea syndrome
  45. Cigarette smoke increases Toll-like receptor 4 and modifies lipopolysaccharide-mediated responses in airway epithelial cells
  46. Medico-legal implications of sleep apnoea syndrome: Driving license regulations in Europe
  47. Effects of Exercise Training and Montelukast in Children with Mild Asthma
  48. Bronchial responsiveness and airway inflammation in trained subjects
  49. Metabolic effects of the obstructive sleep apnea syndrome and cardiovascular risk
  50. Endurance Training Damages Small Airway Epithelium in Mice
  51. "SLEEP APNOEA AS AN INDEPENDENT RISK FACTOR FOR CARDIOVASCULAR DISEASE: CURRENT EVIDENCE, BASIC MECHANISMS AND RESEARCH PRIORITIES". W.T. MCNICHOLAS, M.R. BONSIGNORE AND THE MANAGEMENT COMMITTEE OF EU COST ACTION B26. EUR RESPIR J 2007; 29: 156-178.
  52. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities
  53. Baroreflex control of heart rate during sleep in severe obstructive sleep apnoea: effects of acute CPAP
  54. Supramaximal exercise mobilizes hematopoietic progenitors and reticulocytes in athletes
  55. “Light” smoking and dependence symptoms in high-school students
  56. Airway inflammation in patients affected by obstructive sleep apnea syndrome
  57. Increased airway inflammatory cells in endurance athletes: what do they mean?
  58. Continuous Positive Airway Pressure Treatment Improves Baroreflex Control of Heart Rate during Sleep in Severe Obstructive Sleep Apnea Syndrome
  59. Sleep apnoea and hypertension
  60. Sleep Structure Correlates of Continuous Positive Airway Pressure Variations During Application of an Autotitrating Continuous Positive Airway Pressure Machine in Patients With Obstructive Sleep Apnea Syndrome
  61. Influence of sampling interval on the evaluation of nocturnal blood pressure in subjects with and without obstructive sleep apnoea
  62. Myocardial ischemia during sleep
  63. Ventilation and entrainment of breathing during cycling and running in triathletes
  64. Autonomic cardiac regulation in obstructive sleep apnea syndrome